LIVZON PHARMACEUTICAL GROUP INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.41 CNY | +0.33% |
|
-3.50% | +12.57% |
| 05-14 | Livzon Pharmaceutical Group Cancels Share Options | MT |
| 05-14 | Livzon Pharmaceutical Declares Final Dividend for 2023 | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 13.35B 1.84B 2.51B | Sales 2025 * | 14.47B 2B 2.73B | Capitalization | 32.38B 4.48B 6.1B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.16B 298M 406M | Net income 2025 * | 2.45B 339M 461M | EV / Sales 2024 * | 1.9 x |
| Net cash position 2024 * | 7.04B 973M 1.33B | Net cash position 2025 * | 7.36B 1.02B 1.39B | EV / Sales 2025 * | 1.73 x |
| P/E ratio 2024 * |
17
x | P/E ratio 2025 * |
14.8
x | Employees | 8,933 |
| Yield 2024 * |
4.2% | Yield 2025 * |
4.7% | Free-Float | 38.36% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.33% | ||
| 1 week | -3.50% | ||
| Current month | -1.72% | ||
| 1 month | +4.12% | ||
| 3 months | +3.47% | ||
| 6 months | +14.13% | ||
| Current year | +12.57% |
1 week
38.81
40.82
1 month
36.4641.47
Current year
32.7041.47
1 year
31.7241.47
3 years
28.8852.36
5 years
22.1562.20
10 years
15.2562.20
| Managers | Title | Age | Since |
|---|---|---|---|
Yang Gang Tang
PSD | President | 55 | 18-07-16 |
Yan Xia Si
DFI | Director of Finance/CFO | 56 | 93-03-31 |
Maolin Wang
CHM | Chairman | 59 | 00-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bao Guo Zhu
CHM | Chairman | 62 | 01-12-31 |
Qing Feng Qiu
BRD | Director/Board Member | 53 | 07-03-31 |
Hua Min Huang
BRD | Director/Board Member | 53 | 13-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.42% | 4 M€ | -2.96% | ||
| 0.36% | 2 M€ | -13.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-20 | 39.41 | +0.33% | 3,961,280 |
| 24-05-17 | 39.28 | -1.06% | 5,394,104 |
| 24-05-16 | 39.7 | -1.49% | 4,821,321 |
| 24-05-15 | 40.3 | -0.79% | 4,193,829 |
| 24-05-14 | 40.62 | -0.54% | 8,608,383 |
End-of-day quote Shenzhen S.E., May 19, 2024
More quotes
LIVZON PHARMACEUTICAL GROUP INC. is a China based company principally engaged in the research and development, production and sales of pharmaceutical products. The Company's main products include western medicine preparation such as gastrointestinal drugs, cardiovascular drugs and antimicrobial drugs and gonadotrophin drugs, Chinese medicine preparation, active pharmaceutical ingredient and intermediates, diagnostic reagents and equipments. The Company distributes its products in the domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-06-14
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
39.41
CNY
Average target price
41.14
CNY
Spread / Average Target
+4.39%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.57% | 4.47B | |
| +34.35% | 693B | |
| +29.39% | 584B | |
| -3.49% | 372B | |
| +20.15% | 332B | |
| +6.19% | 294B | |
| +14.11% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +9.21% | 168B |
- Stock Market
- Equities
- 000513 Stock
